Skip to main content

News

Press Release
07/07/2020
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The...
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The...
Abbott announced that the U.S....
07/07/2020
EP Lab Digest
Press Release
07/06/2020
More studies show how COVID-19 aftermath survival may be driven by heart conditions across all demographics. InfoBionic explains why remote cardiac monitoring will be foundational to improving patient outcomes in an evolving long term. As...
More studies show how COVID-19 aftermath survival may be driven by heart conditions across all demographics. InfoBionic explains why remote cardiac monitoring will be foundational to improving patient outcomes in an evolving long term. As...
More studies show how COVID-19...
07/06/2020
EP Lab Digest
Press Release
07/06/2020
Researchers from the Moscow Institute of Physics and Technology, Kazan Federal University, and George Washington University have proposed an algorithm for producing patient-specific mathematical models describing the electrical excitation of...
Researchers from the Moscow Institute of Physics and Technology, Kazan Federal University, and George Washington University have proposed an algorithm for producing patient-specific mathematical models describing the electrical excitation of...
Researchers from the Moscow...
07/06/2020
EP Lab Digest
Press Release
07/02/2020
inHEART, providing a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a round of EUR 3.7 million led by Elaia. These funds will be used to accelerate commercial development...
inHEART, providing a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a round of EUR 3.7 million led by Elaia. These funds will be used to accelerate commercial development...
inHEART, providing a cloud-based...
07/02/2020
EP Lab Digest
Press Release
07/02/2020
The first published United States experience of patients who received Abiomed’s newest heart pump, Impella 5.5 with SmartAssist, finds 84% of the patients survived to explant with 76% native heart recovery. The study was published in the July...
The first published United States experience of patients who received Abiomed’s newest heart pump, Impella 5.5 with SmartAssist, finds 84% of the patients survived to explant with 76% native heart recovery. The study was published in the July...
The first published United...
07/02/2020
EP Lab Digest
Press Release
07/01/2020
Announces Launch of Commercial Sales in Europe   The Globe mapping and ablation catheter from Kardium. (Photo: Business Wire)   Kardium Inc. has received CE mark approval for its Globe Mapping and Ablation System – the most complete...
Announces Launch of Commercial Sales in Europe   The Globe mapping and ablation catheter from Kardium. (Photo: Business Wire)   Kardium Inc. has received CE mark approval for its Globe Mapping and Ablation System – the most complete...
Announces Launch of Commercial...
07/01/2020
EP Lab Digest
Press Release
06/30/2020
BAROSTIM NEO™ is the World's First Heart Failure Neuromodulation Device CVRx, Inc., a private medical device company, announced that its BeAT-HF phase III randomized clinical trial results were published in the Journal of the American...
BAROSTIM NEO™ is the World's First Heart Failure Neuromodulation Device CVRx, Inc., a private medical device company, announced that its BeAT-HF phase III randomized clinical trial results were published in the Journal of the American...
BAROSTIM NEO™ is the World's...
06/30/2020
EP Lab Digest
Press Release
06/30/2020
The Press Program for ESC Congress – the world’s largest cardiovascular event – was revealed today. Journalists from around the globe are invited to the Opening Press Conference on Saturday, August 29, and four embargoed Hot Line Press...
The Press Program for ESC Congress – the world’s largest cardiovascular event – was revealed today. Journalists from around the globe are invited to the Opening Press Conference on Saturday, August 29, and four embargoed Hot Line Press...
The Press Program for ESC...
06/30/2020
EP Lab Digest
Press Release
06/30/2020
Ancora Heart, Inc., a company developing a novel therapy to address heart failure, announced U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) application for the CorCinch-HF pivotal study, which...
Ancora Heart, Inc., a company developing a novel therapy to address heart failure, announced U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) application for the CorCinch-HF pivotal study, which...
Ancora Heart, Inc., a company...
06/30/2020
EP Lab Digest
Press Release
06/30/2020
Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, announced it has acquired 510 Kardiac Devices, Inc., a privately-held medical device company and makers of the Lim Transseptal...
Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, announced it has acquired 510 Kardiac Devices, Inc., a privately-held medical device company and makers of the Lim Transseptal...
Keystone Heart, LTD., a medical...
06/30/2020
EP Lab Digest